Clincosm LogoSign in Get a demo

Advanced Breast Cancer

Showing 76 - 100 of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Kolkata (Hypo fractionated whole breast radiotherapy)

Unknown status
  • Breast Cancer
  • +2 more
  • Hypo fractionated whole breast radiotherapy
  • Kolkata, West Bengal, India
    Sanjoy Chatterjee
Dec 2, 2021

Advanced Breast Cancer, Metastatic Breast Cancer Trial in China (MRG002)

Recruiting
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Hefei, Anhui, China
  • +18 more
Nov 29, 2021

Advanced Breast Cancer Trial in Philadelphia (Ribociclib (LEE011), Paclitaxel)

Active, not recruiting
  • Advanced Breast Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 28, 2021

Advanced Breast Cancer Trial in Shenyang (Chidamide, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Shenyang, Liaoning, China
    Liangning Tumor Hospital &Institute
Sep 8, 2021

Advanced Breast Cancer Trial (Trastuzumab and Pyrotinib)

Not yet recruiting
  • Advanced Breast Cancer
  • Trastuzumab and Pyrotinib
  • (no location specified)
Aug 24, 2021

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer Trial in Philadelphia (Palbociclib, Olaparib,

Recruiting
  • Metastatic Breast Cancer
  • +4 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 20, 2021

Advanced Breast Cancer, Metastatic Breast Cancer Trial in Maastricht

Recruiting
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
    • Maastricht, Netherlands
      Multiple hospitals in the Netherlands (see Eligibility)
    Jul 8, 2021

    Advanced Breast Cancer Trial in Beijing (Entinostat, Placebo, Exemestane)

    Active, not recruiting
    • Advanced Breast Cancer
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy Medical Sciences
    Jul 7, 2021

    Advanced Breast Cancer Trial (PFMT educational intervention)

    Not yet recruiting
    • Advanced Breast Cancer
    • PFMT educational intervention
    • (no location specified)
    Jul 7, 2021

    Metastatic Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer Trial in United Kingdom (Ipatasertib 300mg, Fulvestrant

    Not yet recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Ipatasertib 300mg
    • +3 more
    • Cambridge, Cambridgeshire, United Kingdom
    • +19 more
    Jun 3, 2021

    Advanced Breast Cancer Trial in Beijing (SHR6390, Placebo, Fulvestrant)

    Active, not recruiting
    • Advanced Breast Cancer
    • Beijing, Beijing, China
      Chinese Academy of Medical Science
    May 31, 2021

    Advanced Breast Cancer Trial in China (SHR6390, Letrozole or anastrozole or Fulvestrant)

    Active, not recruiting
    • Advanced Breast Cancer
    • SHR6390
    • Letrozole or anastrozole or Fulvestrant
    • Ha'erbin, Heilongjiang, China
    • +3 more
    May 31, 2021

    Advanced Breast Cancer Trial in Shanghai (SHR6390 Tablets, Placebo Tablets, Letrozole or Anastrozole Tablets)

    Active, not recruiting
    • Advanced Breast Cancer
    • SHR6390 Tablets
    • +2 more
    • Shanghai, China
      Nayima Bayaxi
    May 31, 2021

    Advanced Breast Cancer Trial in Seoul (Talazoparib Oral Capsule)

    Recruiting
    • Advanced Breast Cancer
    • Talazoparib Oral Capsule
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    May 14, 2021

    Advanced Breast Cancer Trial (CYH33, Fulvestrant, Letrozole)

    Not yet recruiting
    • Advanced Breast Cancer
    • (no location specified)
    Apr 19, 2021

    Advanced Breast Cancer Trial (POL6326, Eribulin, Nab paclitaxel)

    Not yet recruiting
    • Advanced Breast Cancer
    • (no location specified)
    Apr 6, 2021

    Advanced Breast Cancer, Advanced Nonsmall Cell Lung Cancer, Advanced Gastric Cancer Trial in United States (XMT-1522)

    Completed
    • Advanced Breast Cancer
    • +2 more
    • Tampa, Florida
    • +4 more
    Feb 23, 2021

    Advanced Ovarian Cancer, Primary Peritoneal Cancer, Advanced Breast Cancer Trial run by the NCI (BMN 673)

    Completed
    Has Results
    • Advanced Ovarian Cancer
    • +3 more
    • BMN 673
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Feb 2, 2021

    Advanced Breast Cancer Trial (Irinotecan Liposome Injection)

    Not yet recruiting
    • Advanced Breast Cancer
    • Irinotecan Liposome Injection
    • (no location specified)
    Jan 26, 2021

    Lung Cancer, Breast Cancer, Brain Cancer Trial in United Kingdom (Afatinib, 2 Gy targeted radiotherapy, 4 Gy targeted

    Unknown status
    • Lung Cancer
    • +4 more
    • Cambridge, England, United Kingdom
    • +5 more
    Jan 12, 2021

    Advanced Breast Cancer Trial in Beijing (LXI-15029, LXI-15029+Exemestane)

    Unknown status
    • Advanced Breast Cancer
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Dec 31, 2020

    Advanced Breast Cancer Trial in Lille (specimen sample collection)

    Recruiting
    • Advanced Breast Cancer
    • specimen sample collection
    • Lille, France
      Centre Oscar Lambret
    Nov 27, 2020

    Advanced Breast Cancer Trial in Shanghai (LX-039 tablets)

    Enrolling by invitation
    • Advanced Breast Cancer
    • LX-039 tablets
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 19, 2020

    Advanced Breast Cancer Trial in Guangzhou (Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Breast Cancer,

    Withdrawn
    • Advanced Breast Cancer
    • Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Breast Cancer
    • cryotherapy
    • Guangzhou, Guangdong, China
      Institutional Review Board of Guangzhou Fuda Cancer Hospital
    Oct 13, 2020

    Metastasis Solid Tumors, Advanced Breast Cancer Trial in Beijing (XZP-3287)

    Unknown status
    • Metastasis Solid Tumors
    • Advanced Breast Cancer
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Sep 3, 2020